Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery

A Randomized, Double-masked, Parallel Group Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery (Levofloxacin 0.5% Ophthalmic Solution as a Comparator) - Phase III, Confirmatory Study of Perioperative Bacteria Eradication -

The purpose of this study is to evaluate superior efficacy of DE-108 ophthalmic solution to that of Levofloxacin 0.5% ophthalmic solution as well as safety of the former used for perioperative bacteria eradication in patients who are scheduled for cataract surgery.

Inclusion Criteria:

• Those who are scheduled for cataract surgery

Exclusion Criteria:

• Those who with suspected ocular infections based on clinical findings in the study eye.
• Those who have any eye disease other than cataract which requires treatment in the target eye.
• Those who have a history of allergy to the drugs to be used during the clinical study (such as fluoroquinolones, topical anesthetics and povidon iodine)
• Those who need to wear contact lenses during the study period